161 related articles for article (PubMed ID: 31222761)
41. Voltage-gated sodium channels contribute to action potentials and spontaneous contractility in isolated human lymphatic vessels.
Telinius N; Majgaard J; Kim S; Katballe N; Pahle E; Nielsen J; Hjortdal V; Aalkjaer C; Boedtkjer DB
J Physiol; 2015 Jul; 593(14):3109-22. PubMed ID: 25969124
[TBL] [Abstract][Full Text] [Related]
42. Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling.
House CD; Wang BD; Ceniccola K; Williams R; Simaan M; Olender J; Patel V; Baptista-Hon DT; Annunziata CM; Gutkind JS; Hales TG; Lee NH
Sci Rep; 2015 Jun; 5():11541. PubMed ID: 26096612
[TBL] [Abstract][Full Text] [Related]
43. Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities.
Wannous R; Bon E; Gillet L; Chamouton J; Weber G; Brisson L; Goré J; Bougnoux P; Besson P; Roger S; Chevalier S
Pflugers Arch; 2015 Jun; 467(6):1249-59. PubMed ID: 25017107
[TBL] [Abstract][Full Text] [Related]
44. Voltage gated sodium channels in cancer and their potential mechanisms of action.
Angus M; Ruben P
Channels (Austin); 2019 Dec; 13(1):400-409. PubMed ID: 31510893
[TBL] [Abstract][Full Text] [Related]
45. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
46. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
[TBL] [Abstract][Full Text] [Related]
47. The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.
Dulong C; Fang YJ; Gest C; Zhou MH; Patte-Mensah C; Mensah-Nyagan AG; Vannier JP; Lu H; Soria C; Cazin L; Mei YA; Varin R; Li H
Int J Oncol; 2014 Feb; 44(2):539-47. PubMed ID: 24337141
[TBL] [Abstract][Full Text] [Related]
48. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
49. Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine.
Sokolov S; Peters CH; Rajamani S; Ruben PC
Front Pharmacol; 2013; 4():78. PubMed ID: 23801963
[TBL] [Abstract][Full Text] [Related]
50. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol: inhibitory effects on metastatic cell behaviors and voltage-gated Na⁺ channel activity in rat prostate cancer in vitro.
Fraser SP; Peters A; Fleming-Jones S; Mukhey D; Djamgoz MB
Nutr Cancer; 2014; 66(6):1047-58. PubMed ID: 25102135
[TBL] [Abstract][Full Text] [Related]
52. Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel.
Uysal-Onganer P; Djamgoz MB
Mol Cancer; 2007 Nov; 6():76. PubMed ID: 18036246
[TBL] [Abstract][Full Text] [Related]
53. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
[TBL] [Abstract][Full Text] [Related]
54. beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration.
Işeri OD; Sahin FI; Terzi YK; Yurtcu E; Erdem SR; Sarialioglu F
Pharm Biol; 2014 Nov; 52(11):1374-81. PubMed ID: 25026350
[TBL] [Abstract][Full Text] [Related]
55. Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.
González-González L; González-Ramírez R; Flores A; Avelino-Cruz JE; Felix R; Monjaraz E
Oncology; 2019; 97(6):373-382. PubMed ID: 31430760
[TBL] [Abstract][Full Text] [Related]
56. Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.
Gómez-Contreras P; Ramiro-Díaz JM; Sierra A; Stipp C; Domann FE; Weigel RJ; Lal G
Clin Exp Metastasis; 2017 Jan; 34(1):37-49. PubMed ID: 27770373
[TBL] [Abstract][Full Text] [Related]
57. Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells.
Xing D; Wang J; Ou S; Wang Y; Qiu B; Ding D; Guo F; Gao Q
Oncol Rep; 2014 Jun; 31(6):2692-700. PubMed ID: 24756536
[TBL] [Abstract][Full Text] [Related]
58. Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells.
Fernandez-Gallardo M; González-Ramírez R; Sandoval A; Felix R; Monjaraz E
PLoS One; 2016; 11(12):e0167445. PubMed ID: 27911956
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
[TBL] [Abstract][Full Text] [Related]
60. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
